Skip to Main Content

Paper Details

SGLT2 Inhibitors Are Associated With Reduced Cardiovascular Disease in Patients With Type 2 Diabetes: An Analysis of Real-World Data.
0
2023
CVD, Cardiovascular Disease, Patients, SGLT2, Type 2 Diabetes, atrial fibrillation, cardiovascular disease, diabetes, glucose, heart failure, myocardial infarction, patients, sodium, sodium-glucose cotransporter-2, stroke, type 2 diabetes
Author NameAffiliation
James S PankowSchool of Public Health, University of Minnesota
  • 1 - 1

Datasets

Release 1.2